✦ LIBER ✦

Designing phase II B trials in sarcopenia: The best target population

✍ Scribed by M. Pahor; Matteo Cesari

Book ID: 107671164
Publisher: Springer
Year: 2011
Tongue: English
Weight: 149 KB
Volume: 15
Category: Article
ISSN: 1279-7707
DOI: 10.1007/s12603-011-0058-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The conduct of phase I-II clinical trial

The conduct of phase I-II clinical trials in children with cancer

✍ Pratt, Charles B. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud

Response of patients in phase II studies

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

✍ Blackledge, G; Lawton, F; Redman, C; Kelly, K 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 604 KB

Considerations in the Rational Design an

Considerations in the Rational Design and Conduct of Phase I/II Pediatric Clinical Trials: Avoiding the Problems and Pitfalls

✍ Abdel-Rahman, S M; Reed, M D; Wells, T G; Kearns, G L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 241 KB

Phase II trial of cis-dichlorodiamminepl

Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: A study of the cancer and acute leukemia group B

✍ F. Cavalli; Dr. W. F. Jungi; N. I. Nissen; T. F. Pajak; M. Coleman; J. F. Hollan 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 3 views

In a cooperative study of the Cancer and Acute Leukemia Group B, 27 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cisdichlorodiammineplatinum(l1) (cis-platinum) once every three weeks. All patients had received extensive prior therapy. Partial remission was obtai

A phase II trial of 5-fluorouracil, leuc

A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas

✍ Werner Scheithauer; Franz Pfeffel; Gabriela Kornek; Arthur Marczell; Christoph W 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 2 views

Cancer and Leukemia Group B (CALGB) 8980

Cancer and Leukemia Group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas

✍ A.W. Blackstock; M.A. Tempero; D. Niedwiecki; D.R. Hollis; R.J. Mayer; J.E. Tepp 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 16 KB